ClinicalTrials.Veeva

Menu
Dermatology of Seattle and Bellevue | Burien, WA logo

Dermatology of Seattle and Bellevue | Burien, WA

Research site

Site insights

Top conditions

Top treatments

Ixekizumab
Tirzepatide
Lunsekimig
SAR443765
VDPHL01
LY2439821
Povorcitinib

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Stacey Gomez

Verified by this site

Active trials

6 of 6 total trials

A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma

This is a multi-center clinical study enrolling up to 86 participants. The primary objectives are to determine the objective response rate (ORR) esta...

Enrolling
Recurrent Squamous Cell Carcinoma
Device: DaRT seeds

The purpose of this study is to evaluate effect of povorcitinib on itch and skin lesions in participants with prurigo nodularis.

Enrolling
Prurigo Nodularis
Drug: Placebo
Drug: Povorcitinib

The main purpose of this study is to assess the effectiveness of adding tirzepatide to ixekizumab therapy in standard clinical practice in participan...

Enrolling
Psoriasis
Overweight or Obesity
Drug: Tirzepatide

This is a parallel, Phase 2b, randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy, safety, and tolerability of lun...

Enrolling
Dermatitis Atopic
Drug: Lunsekimig
Drug: Placebo

The main purpose of this study is to demonstrate that when participants with moderate to severe plaque psoriasis and obesity or overweight in the pre...

Enrolling
Psoriasis
Obesity
Drug: Tirzepatide
Drug: Ixekizumab

This study will evaluate the safety and efficacy of VDPHL01 in male and female subjects with Androgenetic Alopecia (AGA).AGA (or pattern of hair loss...

Enrolling
Male Pattern Baldness
AGA
Drug: VDPHL01

Trial sponsors

Lilly logo
A
Incyte logo
Sanofi logo
V

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems